Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced synthesis of chiral spiro bisphosphine ligands via Pd-catalyzed coupling. Delivers high-purity intermediates for asymmetric catalysis with scalable manufacturing.
Novel patent CN108358866A enables high-purity Febuxostat intermediate production with reduced toxicity and enhanced supply chain reliability for global pharmaceutical manufacturers.
Patent CN116041345B reveals copper-catalyzed synthesis of hydantoin skeletons. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN107501153A reveals a novel two-step synthesis for trifluoroethyl aziridines. This method offers significant cost reduction and supply chain reliability for high-purity pharmaceutical intermediates.
Patent CN111690947B reveals a metal-free electrochemical synthesis for trifluoromethylated arylamides, offering significant cost reduction in API manufacturing and greener processing.
Advanced preparation method for high-purity 1-adamantanol offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN115260080B reveals efficient Pd-catalyzed carbonylation. Enhances supply chain reliability and reduces manufacturing costs for high-purity intermediates.
Patent CN115286553B reveals a novel nickel-catalyzed method for indole synthesis. Discover cost-effective, scalable pharmaceutical intermediate manufacturing solutions.
Novel metal-free route for 5-trifluoromethyl triazoles offers significant cost reduction in pharma manufacturing and establishes a reliable pharmaceutical intermediates supplier capability for global buyers.
Patent CN112480015B details a novel one-pot synthesis of 2-trifluoromethyl quinazolinones using nitro compounds, offering significant cost reduction in API manufacturing.
Novel Pd-catalyzed carbonylation using benzyl formate for high-purity aryl acetamides. Reduces oxidant use and simplifies supply chains for pharma intermediates.
Patent CN114478375A details a novel Pd-catalyzed route to quinolin-2(1H)ones using o-nitrobenzaldehyde, offering cost reduction in API manufacturing and scalable supply.
Novel Mo/Cu co-catalyzed method offers high yields and mild conditions for scalable production of bioactive heterocycles.
Patent CN111675662B reveals a novel FeCl3-catalyzed route for quinazolinones. Discover cost-effective manufacturing and supply chain advantages for pharmaceutical intermediates.
Novel cobalt-catalyzed C-H activation method for 2-alkoxyindoles. Reduces steps, enhances supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN111675662B reveals a cost-effective FeCl3-catalyzed route for 2-trifluoromethyl quinazolinones, offering significant supply chain advantages for API manufacturing.
Patent CN113087742B details a novel synthesis for phosphine chiral center compounds using stable oxides. Enables cost-effective production of high-purity catalysts.
Patent CN114409515B reveals a metal-free route to gem-difluoroalkenes using diphenylphosphine oxide, offering cost-effective manufacturing for pharma intermediates.
Advanced synthesis of veterinary drug intermediate using bis(trichloromethyl) carbonate for safer, scalable production with high purity.
Novel heating-promoted synthesis of 2-trifluoromethyl quinolines without metal catalysts. Offers cost reduction and supply chain reliability for pharmaceutical intermediates.